These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12830778)

  • 1. Managing hypertension in patients with stroke. Are you prepared for labetalol infusion?
    Harrington C
    Crit Care Nurse; 2003 Jun; 23(3):30-8. PubMed ID: 12830778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine.
    McKay C; Hall AB; Cortes J
    J Neurosci Nurs; 2015 Dec; 47(6):327-32. PubMed ID: 26528950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
    Hecht JP; Richards PG
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay to Tissue Plasminogen Activator in Hypertensive Stroke Patients: An Analysis of Delay Duration Across Agents.
    Carrera JF; Sorace BJ; Worrall BB; Southerland AM; Chiota-McCollum NA
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104525. PubMed ID: 31812455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of physiologic derangement in patients with stroke treated with thrombolysis.
    Idicula TT; Waje-Andreassen U; Brogger J; Naess H; Lundstadsveen MT; Thomassen L
    J Stroke Cerebrovasc Dis; 2008; 17(3):141-6. PubMed ID: 18436155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of blood pressure management in neurologic emergencies.
    Talbert RL
    Pharmacotherapy; 2006 Aug; 26(8 Pt 2):123S-130S. PubMed ID: 16863478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous labetalol in the emergency treatment of hypertension.
    Vidt DG
    J Clin Hypertens; 1985 Jun; 1(2):179-86. PubMed ID: 3915322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
    El-Ghoroury H; Sudekum DM; Hecht JP
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105959. PubMed ID: 34217067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences?
    Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH
    Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's the "hyper" in hyperacute stroke? Strategies to improve outcomes in ischemic stroke patients presenting within 6 hours.
    Bader MK; Palmer S
    AACN Adv Crit Care; 2006; 17(2):194-214. PubMed ID: 16767022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children.
    Thomas CA; Moffett BS; Wagner JL; Mott AR; Feig DI
    Pediatr Crit Care Med; 2011 Jan; 12(1):28-32. PubMed ID: 20495503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycaemia secondary to labetalol infusion.
    Immanni S; Khan EI; Staunton M
    J Coll Physicians Surg Pak; 2011 May; 21(5):297-8. PubMed ID: 21575539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of labetalol versus nicardipine for blood pressure management in patients with acute stroke.
    Liu-DeRyke X; Levy PD; Parker D; Coplin W; Rhoney DH
    Neurocrit Care; 2013 Aug; 19(1):41-7. PubMed ID: 23760911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should all stroke patients receive tissue plasminogen activator therapy, despite mild or improving symptoms?
    Lyden PD
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):184-5. PubMed ID: 16568123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.